Nivolumab Combined with Ibrutinib for CLL and Richter Transformation: A Phase II Trial

被引：22

作者：

Jain, Nitin ^{[1
]}

Basu, Sreyashi ^{[2
]}

Thompson, Philip A. ^{[1
]}

Ohanian, Maro ^{[1
]}

Ferrajoli, Alessandra ^{[1
]}

Pemmaraju, Naveen ^{[1
]}

Cortes, Jorge E. ^{[1
]}

Estrov, Zeev ^{[1
]}

Burger, Jan A. ^{[1
]}

Neelapu, Sattva S. ^{[3
]}

Lopez, Wanda ^{[1
]}

Thakral, Beenu ^{[4
]}

Bueso-Ramos, Carlos E. ^{[4
]}

Blando, Jorge ^{[2
]}

O'Brien, Susan M. ^{[5
]}

Kantarjian, Hagop M. ^{[1
]}

Allison, James ^{[2
]}

Keating, Michael ^{[1
]}

Sharma, Padmanee ^{[2
]}

Wierda, William G. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX USA

[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.59.59

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] A Phase II Trial of Nivolumab Combined with Ibrutinib for Patients with Richter Transformation
Jain, Nitin
Ferrajoli, Alessandra
Basu, Sreyashi
Thompson, Philip A.
Burger, Jan A.
Kadia, Tapan M.
Estrov, Zeev E.
Pemmaraju, Naveen
Lopez, Wanda
Thakral, Beenu
Khoury, Joseph David
Bueso-Ramos, Carlos E.
Blando, Jorge
O'Brien, Susan M.
Kantarjian, Hagop M.
Allison, James P.
Keating, Michael J.
Sharma, Padmanee
Wierda, William G.
[J]. BLOOD, 2018, 132
[2] A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL
Jain, Nitin
Senapati, Jayastu
Thakral, Beenu
Ferrajoli, Alessandra
Thompson, Philip
Burger, Jan
Basu, Sreyashi
Kadia, Tapan
Daver, Naval
Borthakur, Gautam
Konopleva, Marina
Pemmaraju, Naveen
Parry, Erin
Wu, Catherine J.
Khoury, Joseph
Bueso-Ramos, Carlos
Garg, Naveen
Wang, Xuemei
Lopez, Wanda
Ayala, Ana
O'Brien, Susan
Kantarjian, Hagop
Keating, Michael
Allison, James
Sharma, Padmane
Wierda, William
[J]. BLOOD ADVANCES, 2023, 7 (10) : 1958 - 1966
[3] Combined Venetoclax and Ibrutinib for Patients with Previously Untreated High-Risk CLL, and Relapsed/Refractory CLL: A Phase II Trial
Jain, Nitin
Thompson, Philip A.
Ferrajoli, Alessandra
Burger, Jan A.
Borthakur, Gautam
Takahashi, Koichi
Bose, Prithviraj
Estrov, Zeev
Jabbour, Elias J.
Konopleva, Marina
Alvarado, Yesid
Kadia, Tapan
Yilmaz, Musa
DiNardo, Courtney D.
Ohanian, Maro
Cortes, Jorge E.
Kanagal-Shamanna, Rashmi
Patel, Keyur
Garg, Naveen
Wang, Xuemei
Fru, Nina
Cruz, Nichole
Gandhi, Varsha
Plunkett, William
Kantarjian, Hagop M.
Keating, Michael J.
Wierda, William G.
[J]. BLOOD, 2017, 130
[4] Richter transformation of CLL
Jain, Nitin
Keating, Michael J.
[J]. EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (08) : 793 - 801
[5] The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation
Reiff, Sean D.
Mantel, Rose
Smith, Lisa L.
Greene, J. T.
Muhowski, Elizabeth M.
Fabian, Catherine A.
Goettl, Virginia M.
Tran, Minh
Harrington, Bonnie K.
Rogers, Kerry A.
Awan, Farrukh T.
Maddocks, Kami
Andritsos, Leslie
Lehman, Amy M.
Sampath, Deepa
Lapalombella, Rosa
Eathiraj, Sudharshan
Abbadessa, Giovanni
Schwart, Brian
Johnson, Amy J.
Byrd, John C.
Woyach, Jennifer A.
[J]. CANCER DISCOVERY, 2018, 8 (10) : 1300 - 1315
[6] IDENTIFICATION OF A STRUCTURALLY NOVEL BTK MUTATION THAT DRIVES IBRUTINIB RESISTANCE IN CLL BUT NOT RICHTER TRANSFORMATION
Wang, Y. L.
Sharma, S.
Galanina, N.
[J]. HAEMATOLOGICA, 2016, 101 : 425 - 425
[7] Ibrutinib Combined with Obinutuzumab and CHOP (I-OCHOP) for Richter Transformation
Lopez, Carlos A.
Wu, Vernon
Rhodes, Joanna M.
Rai, Kanti R.
Barrientos, Jacqueline
[J]. BLOOD, 2021, 138
[8] Clonal Evolution Pattern of Leukemia Progression and Richter Transformation in Ibrutinib-Relapsed CLL Patients
Kadri, Sabah
Lee, Jimmy
Fitzpatrick, Carrie
Galanina, Natalie
Sukhanova, Madina
Venkataraman, Girish
Sharma, Shruti
Long, Bradley
Theissen, Megan
Ming, Mei
Kobzev, Yuri
Kang Wenjun
Guo, Ailin
Wang, Weige V.
Niu, Nifang
Weiner, Howie Lawrence
Thirman, Michael J.
Smith, Sonali M.
Segal, Jeremy P.
Lu, Pin
Wang, Y. Lynn
[J]. BLOOD, 2016, 128 (22)
[9] Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL
Kadri, Sabah
Lee, Jimmy
Fitzpatrick, Carrie
Galanina, Natalie
Sukhanova, Madina
Venkataraman, Girish
Sharma, Shruti
Long, Brad
Petras, Kristin
Theissen, Megan
Ming, Mei
Kobzev, Yuri
Kang, Wenjun
Guo, Ailin
Wang, Weige
Niu, Nifang
Weiner, Howard
Thirman, Michael
Stock, Wendy
Smith, Sonali M.
Nabhan, Chadi
Segal, Jeremy P.
Lu, Pin
Wang, Y. Lynn
[J]. BLOOD ADVANCES, 2017, 1 (12) : 715 - 727
[10] A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System Lymphoma
Westin, Jason R.
Fowler, Nathan H.
Nastoupil, Loretta J.
Neelapu, Sattva S.
Lee, Hun Ju
Hagemeister, Fredrick B.
Rodriguez, Maria Alma
Steiner, Raphael E.
Ahmed, Sairah
Parmar, Simrit
Nair, Ranjit
Harrison, Rebecca
Fayad, Luis
[J]. BLOOD, 2019, 134

← 1 2 3 4 5 →